In contrast, other studies have reported lower levels of THBS4 protein and hypermethylation of THBS4 in colorectal cancer, cutaneous T-cell lymphoma, and bladder cancer with an indication of epigenetic silencing in these tumors [48,49,50]. The gene discussed is THBS4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.